Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pea collagen peptide refers to a dietary supplement or ingredient marketed as a plant-based alternative to traditional animal-derived collagen peptides. While conventional collagen peptides are hydrolyzed proteins derived from animal sources such as bovine, porcine, or marine tissues, "pea collagen peptide" is typically produced by enzymatic hydrolysis of pea protein isolate. It is important to note that true collagen is not found in plants; instead, these products contain short-chain peptides from peas that are intended to mimic the amino acid profile and functional benefits of animal-derived collagen. The primary indications for use include support for skin health (hydration and elasticity), joint health (pain relief and mobility), muscle strength, bone health, and general anti-aging effects[1][2][3]. However, scientific evidence supporting the efficacy of plant-based "collagen" peptides is limited compared to traditional sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pea collagen peptide.